PROVIDER PROFILE · NPI 1609961937
Mark FisherMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
376
Unique beneficiaries
—
Total services
3,995
Distinct HCPCS
10
Medicare payment
$148K
Peer benchmark
Total Medicare services vs. 179 Rheumatology providers in NJ — above median (cohort median 19,050).
PRESCRIBING · PART D · 2024
Total Rx claims
936
Beneficiaries
—
Total drug cost
$835K
Distinct drugs
26
Brand share
26.8%
Top prescribed drugs
Prednisone178 claims
Methotrexate Sodium132 claims
Tizanidine Hcl54 claims
Leflunomide41 claims
Hydroxychloroquine Sulfate37 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$531
Payment records
29
By payment type
Food and Beverage$531
Top paying entities
Food and Beverage$531
REFERRAL NETWORK
Where Mark Fisher's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA | 55 | 103 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 53 | 100 |
| VIRTUA OUR LADY OF LOURDES HOSPITAL INC | 22 | 36 |
| KENNEDY UNIVERSITY HOSPITAL INC. | 11 | 24 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE